These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4085636)

  • 1. [Glycoside poisoning in experimental heart failure and its drug correction].
    Gendenshteĭn EI; Lemkina SM; Sernov LN
    Farmakol Toksikol; 1985; 48(6):83-6. PubMed ID: 4085636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiotoxicity of strophanthin for rats and its correction with anaprilin in coronary-related and non-coronary-related damage to the myocardium and acute cardiac insufficiency].
    Gendenshteĭn ZI; Lemkina SM
    Biull Eksp Biol Med; 1984 Jun; 97(6):683-6. PubMed ID: 6743806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of kordaron on the pharmacodynamic effects of strophanthin in experiments on isolated myocardial preparations and in the modelling of heart failure].
    Lemkina SM
    Eksp Klin Farmakol; 1993; 56(4):30-3. PubMed ID: 8220011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of kordaron, anaprilin, dimedrol and riboxin on the hemodynamic effects of strophanthin in experimental heart failure].
    Gendenshteĭn EI; Lemkina SM
    Farmakol Toksikol; 1988; 51(2):53-6. PubMed ID: 3378606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities for the strophanthin pharmacological correction of cardio- and hemodynamic disorders in dogs in the early stage of experimental lung-heart failure].
    Frantsuzova SB; Antonenko LI; Krivelevich VIa
    Farmakol Toksikol; 1985; 48(4):87-92. PubMed ID: 4043369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological correction of impaired tolerance to strophanthin in a model of cardiac decompensation].
    Galenko-Iaroshevskiĭ PA; Lemkina SM; Kostin IaV
    Biull Eksp Biol Med; 1994 May; 117(5):487-90. PubMed ID: 9296697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of nonseptic cardiogenic circulatory failure].
    Griebenow R
    Klin Anasthesiol Intensivther; 1995; 47():122-8. PubMed ID: 7715169
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of some glycosides on hemodynamics in acute cardiovascular insufficiency].
    Kit SM
    Vrach Delo; 1966 Aug; 8():19-21. PubMed ID: 5989153
    [No Abstract]   [Full Text] [Related]  

  • 9. Principles of drug therapy in heart failure.
    Dey SK; Poflee VW
    Natl Med J India; 1995; 8(2):73-8. PubMed ID: 7735067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of glucagon in cardiac glycoside poisoning in patients with congestive circulatory insufficiency].
    Sivkov SI
    Kardiologiia; 1977 Sep; 17(9):39-42. PubMed ID: 926598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of inflammation mediators in the etiology of hypersensitivity to strophanthin in various experimental heart diseases].
    Gendenshteĭn EI; Sernov LN; Alferov VF
    Biull Eksp Biol Med; 1982 Mar; 93(3):52-5. PubMed ID: 7093484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycoside poisoning: some aspects of the problem].
    Gendenshteĭn EI; Sernov LN
    Ter Arkh; 1986; 58(1):125-7. PubMed ID: 3008361
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical efficacy of taufon in the combined treatment of patients with chronic circulatory failure].
    Zavolovskaia LI; Elizarova EP; Orlov VA
    Eksp Klin Farmakol; 1995; 58(6):29-32. PubMed ID: 8704607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of development of cardiac glycoside poisoning and its drug prevention in circulatory failure].
    Gendenshteĭn EI; Lemkina SM
    Kardiologiia; 1987 Dec; 27(12):107-11. PubMed ID: 3327992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles and directives for practical treatment with cardiac glycosides].
    Dörffel EF
    Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-pharmacologic aspects of cardioactive drugs].
    Erdmann E; Schwinger RH; Böhm M
    Klin Anasthesiol Intensivther; 1995; 47():46-60. PubMed ID: 7715179
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myocardial contractile function in acute heart failure during exposure to strophanthin and its combination with alpha-tocopherol].
    Chekman IS; Frantsuzova SB; Antonenko LI; Gudivok IaS
    Farmakol Toksikol; 1988; 51(4):44-7. PubMed ID: 3191972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ether-oxygen anesthesia and of the premedication agents on the toxicity and cardiotonic effect of strophanthin].
    Gatsura VV; Mitchenko PP
    Farmakol Toksikol; 1975; 38(5):568-71. PubMed ID: 1183587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ouabain on the cardiovascular system of rats with chronic heart failure].
    Gorodetskaia EA; Allabergenova EA; Medvedev OS
    Eksp Klin Farmakol; 1993; 56(1):31-3. PubMed ID: 8324469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of adrenergic and antiadrenergic agents on the toxic effects of strophanthin].
    Gendenshteĭn EI; Volkova ND
    Farmakol Toksikol; 1974; 37(6):727-9. PubMed ID: 4464109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.